To provide a guideline on sarcoidosis treatment.
Two members of the ELF sarcoidosis patient advisory group were nominated as members of the Task force working group. A survey to individuals with sarcoidosis was disseminated across Europe to rate the importance of a range of treatment outcomes and the findings will be incorporated into the final Task force report.
The guideline is due to be published in 2021.
An article by the sarcoidosis patient advisory group: Sarcoidosis: patient treatment priorities was published in ERJ Open Research in December 2018 and highlights the findings of our patient survey, the findings of which will be reflected in the final guideline.
ELF is a non-profit organisation registered as a UK company (VAT no. GB 115 0027 74) and charity (no. 1118930).
Our Brussels office enterprise number is 0738.383.695
European Lung Foundation's TR ID number in the Transparency Register is: 094039644810-79